about
c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's diseaseCharacterization of Molecular Determinants of the Conformational Stability of Macrophage Migration Inhibitory Factor: Leucine 46 Hydrophobic PocketA new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor.Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomerPhosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disordersCharacterization of semisynthetic and naturally Nα-acetylated α-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of α-synuclein.The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.Synthetic polyubiquitinated α-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology.Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies.Chemical strategies for controlling protein folding and elucidating the molecular mechanisms of amyloid formation and toxicity.Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: α-synuclein phosphorylation at tyrosine 125.Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations.Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.One-pot total chemical synthesis of human α-synuclein.Membrane scission driven by the PROPPIN Atg18.Combined voltage and calcium epifluorescence imaging in vitro and in vivo reveals subthreshold and suprathreshold dynamics of mouse barrel cortex.Semisynthesis and Enzymatic Preparation of Post-translationally Modified α-Synuclein.Exploring the role of post-translational modifications in regulating α-synuclein interactions by studying the effects of phosphorylation on nanobody binding.
P50
Q24318974-5F8C6785-4BD6-48B3-AE7E-E38311AD87B7Q27673971-CCE94F61-96B4-4097-B116-EFBE36362BCAQ33500775-5E5E03F1-4C1E-4F40-B30C-4DA68F353F60Q33591955-B61B34C8-CFB1-47E7-8121-39BADE0E63D8Q33635084-E6491B56-2DC4-4BEB-A145-26ADB366C525Q34252869-2F8E376B-3AFA-4517-834E-A824D8D5763AQ36015338-AF6CE299-0E32-4152-9D93-8701B24DB140Q36217340-2C9C24B2-19B3-48ED-AF5F-B3D5EA750A73Q36296532-EFB5BCA0-B6C4-4BEE-920F-AD6B55089956Q37276472-18635306-9CCE-40D1-A5F6-146E493C6A54Q37388974-D85CA2B8-62F3-4659-AE5A-BE7D990DCBD3Q37985331-91055A52-3EED-4044-BEAD-8F6FA9AB9598Q41420722-0FC40327-89CF-4925-B4FF-C9E2D62D86B2Q41728474-5143C370-CD65-403A-8C6E-D59A64E50024Q42366501-32A37505-8A2C-4A2D-9182-B7D79B84AAC1Q44007141-096EEC93-471A-4A11-8756-94E38FAE52ABQ47654966-31BE1CF4-F6E2-4C69-BFC8-4AA89C1FFA33Q48241992-4185775D-F1BC-4A2E-8F61-4335D274E571Q50926158-F8F43383-8A8A-49F3-8699-CFF7A35AFBE0Q53823040-B24C276C-44BD-438F-BDA1-F9804E6E46C4
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Bruno Fauvet
@ast
Bruno Fauvet
@en
Bruno Fauvet
@es
Bruno Fauvet
@nl
type
label
Bruno Fauvet
@ast
Bruno Fauvet
@en
Bruno Fauvet
@es
Bruno Fauvet
@nl
prefLabel
Bruno Fauvet
@ast
Bruno Fauvet
@en
Bruno Fauvet
@es
Bruno Fauvet
@nl
P31
P496
0000-0001-5775-3001